[
  {
    "title": "Novo Nordisk A/S Reports Q3 2023 Earnings Results",
    "description": "Novo Nordisk A/S announces Q3 2023 Earnings financial results with strong performance.",
    "pub_date": "2023-10-25 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/NVO/2023-10-25",
    "analysis_text": "Novo Nordisk A/S Reports Q3 2023 Earnings Results Novo Nordisk A/S announces Q3 2023 Earnings financial results with strong performance."
  },
  {
    "title": "Novo Nordisk Faces Supply Constraints",
    "description": "Novo Nordisk struggles with supply constraints for popular weight loss drugs.",
    "pub_date": "2023-11-14 00:00:00",
    "sentiment_score": -0.6,
    "sentiment_label": "bad",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Historical Events Database",
    "link": "https://example.com/news/NVO/2023-11-14",
    "analysis_text": "Novo Nordisk Faces Supply Constraints Novo Nordisk struggles with supply constraints for popular weight loss drugs."
  },
  {
    "title": "Novo Nordisk A/S - Holiday Season Performance",
    "description": "Company reports strong performance during holiday season.",
    "pub_date": "2023-12-10 00:00:00",
    "sentiment_score": -0.01532819641617017,
    "sentiment_label": "neutral",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/NVO/2023-12-10",
    "analysis_text": "Novo Nordisk A/S - Holiday Season Performance Company reports strong performance during holiday season."
  },
  {
    "title": "Novo Nordisk A/S Reports Q4 2023 Earnings Results",
    "description": "Novo Nordisk A/S announces Q4 2023 Earnings financial results with mixed performance.",
    "pub_date": "2024-01-25 00:00:00",
    "sentiment_score": -0.4,
    "sentiment_label": "bad",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/NVO/2024-01-25",
    "analysis_text": "Novo Nordisk A/S Reports Q4 2023 Earnings Results Novo Nordisk A/S announces Q4 2023 Earnings financial results with mixed performance."
  },
  {
    "title": "Novo Nordisk Reports Record Revenue",
    "description": "Novo Nordisk posts record quarterly revenue driven by strong demand for GLP-1 drugs.",
    "pub_date": "2024-02-07 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Historical Events Database",
    "link": "https://example.com/news/NVO/2024-02-07",
    "analysis_text": "Novo Nordisk Reports Record Revenue Novo Nordisk posts record quarterly revenue driven by strong demand for GLP-1 drugs."
  },
  {
    "title": "Novo Nordisk A/S - Market Analysis Update",
    "description": "Analysts provide updated market analysis and price targets.",
    "pub_date": "2024-03-15 00:00:00",
    "sentiment_score": 0.14257615351398673,
    "sentiment_label": "neutral",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/NVO/2024-03-15",
    "analysis_text": "Novo Nordisk A/S - Market Analysis Update Analysts provide updated market analysis and price targets."
  },
  {
    "title": "Novo Nordisk Ozempic Sales Surge",
    "description": "Novo Nordisk reports record sales of Ozempic diabetes drug, exceeding market expectations.",
    "pub_date": "2024-04-15 00:00:00",
    "sentiment_score": 0.9,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Historical Events Database",
    "link": "https://example.com/news/NVO/2024-04-15",
    "analysis_text": "Novo Nordisk Ozempic Sales Surge Novo Nordisk reports record sales of Ozempic diabetes drug, exceeding market expectations."
  },
  {
    "title": "Novo Nordisk A/S Reports Q1 2024 Earnings Results",
    "description": "Novo Nordisk A/S announces Q1 2024 Earnings financial results with strong performance.",
    "pub_date": "2024-04-25 00:00:00",
    "sentiment_score": 0.7,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/NVO/2024-04-25",
    "analysis_text": "Novo Nordisk A/S Reports Q1 2024 Earnings Results Novo Nordisk A/S announces Q1 2024 Earnings financial results with strong performance."
  },
  {
    "title": "Novo Nordisk A/S - Industry Conference Participation",
    "description": "Company participates in major industry conference with positive reception.",
    "pub_date": "2024-06-10 00:00:00",
    "sentiment_score": 0.34882791395999685,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/NVO/2024-06-10",
    "analysis_text": "Novo Nordisk A/S - Industry Conference Participation Company participates in major industry conference with positive reception."
  },
  {
    "title": "Novo Nordisk Wegovy Gets Expanded Approval",
    "description": "FDA expands approval for Novo Nordisk's Wegovy weight loss drug to broader patient population.",
    "pub_date": "2024-07-22 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Historical Events Database",
    "link": "https://example.com/news/NVO/2024-07-22",
    "analysis_text": "Novo Nordisk Wegovy Gets Expanded Approval FDA expands approval for Novo Nordisk's Wegovy weight loss drug to broader patient population."
  },
  {
    "title": "Novo Nordisk A/S Reports Q2 2024 Earnings Results",
    "description": "Novo Nordisk A/S announces Q2 2024 Earnings financial results with mixed performance.",
    "pub_date": "2024-07-25 00:00:00",
    "sentiment_score": -0.4,
    "sentiment_label": "bad",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/NVO/2024-07-25",
    "analysis_text": "Novo Nordisk A/S Reports Q2 2024 Earnings Results Novo Nordisk A/S announces Q2 2024 Earnings financial results with mixed performance."
  },
  {
    "title": "Novo Nordisk A/S - Regulatory Update",
    "description": "Company provides update on regulatory matters and compliance.",
    "pub_date": "2024-09-05 00:00:00",
    "sentiment_score": 0.5596368621875898,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/NVO/2024-09-05",
    "analysis_text": "Novo Nordisk A/S - Regulatory Update Company provides update on regulatory matters and compliance."
  },
  {
    "title": "Novo Nordisk Announces New Manufacturing Plant",
    "description": "Novo Nordisk announces construction of new manufacturing facility to address supply issues.",
    "pub_date": "2024-10-02 00:00:00",
    "sentiment_score": 0.7,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Historical Events Database",
    "link": "https://example.com/news/NVO/2024-10-02",
    "analysis_text": "Novo Nordisk Announces New Manufacturing Plant Novo Nordisk announces construction of new manufacturing facility to address supply issues."
  },
  {
    "title": "Novo Nordisk A/S Reports Q3 2024 Earnings Results",
    "description": "Novo Nordisk A/S announces Q3 2024 Earnings financial results with strong performance.",
    "pub_date": "2024-10-25 00:00:00",
    "sentiment_score": 0.8,
    "sentiment_label": "good",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Earnings Events",
    "link": "https://example.com/earnings/NVO/2024-10-25",
    "analysis_text": "Novo Nordisk A/S Reports Q3 2024 Earnings Results Novo Nordisk A/S announces Q3 2024 Earnings financial results with strong performance."
  },
  {
    "title": "Novo Nordisk A/S - Year-End Guidance Update",
    "description": "Company updates full-year guidance based on current performance.",
    "pub_date": "2024-11-20 00:00:00",
    "sentiment_score": -0.1961168724480103,
    "sentiment_label": "neutral",
    "ticker": "NVO",
    "company_name": "Novo Nordisk A/S",
    "source": "Simulated Market Events",
    "link": "https://example.com/market/NVO/2024-11-20",
    "analysis_text": "Novo Nordisk A/S - Year-End Guidance Update Company updates full-year guidance based on current performance."
  }
]